Future studies are necessary to evaluate possible dose-dependent differences as well as effects of IL-6 administration in vivo in lean and obese subjects to specify the meaning of an obesity-induced increase of IL-6 concentration on NK cell physiology. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.